Global burden of gout in 1990–2019: A systematic analysis of the Global Burden of Disease study 2019

Although gout is one of the most common rheumatic diseases, world data are lacking because most studies have focused on industrialized countries. Therefore, we aimed to investigate the global burden of gout and its associations with the year of diagnosis, age, geographical region, sociodemographic status and various further risk factors.

[1]  P. Jia,et al.  Changes in dietary patterns among youths in China during COVID-19 epidemic: The COVID-19 impact on lifestyle change survey (COINLICS) , 2020, Appetite.

[2]  P. Jia,et al.  Impact of COVID-19 lockdown on activity patterns and weight status among youths in China: the COVID-19 Impact on Lifestyle Change Survey (COINLICS) , 2020, International Journal of Obesity.

[3]  Eun Sug Park,et al.  Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 , 2020, Lancet.

[4]  Saranya Sasidharan,et al.  Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[5]  G. Collins,et al.  Prevalence, Incidence, and Years Lived With Disability Due to Gout and Its Attributable Risk Factors for 195 Countries and Territories 1990–2017: A Systematic Analysis of the Global Burden of Disease Study 2017 , 2020, Arthritis & rheumatology.

[6]  K. Niu,et al.  Global, regional and national burden of gout, 1990-2017: a systematic analysis of the Global Burden of Disease Study. , 2019, Rheumatology.

[7]  L. G. Vu,et al.  Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.

[8]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[9]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[10]  Hyon K. Choi,et al.  The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet, and risk of gout in men: prospective cohort study , 2017, British Medical Journal.

[11]  Kyung-Su Park,et al.  Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study , 2015, Arthritis Research & Therapy.

[12]  A. Abeles.  Hyperuricemia, Gout, and Cardiovascular Disease: An Update , 2015, Current Rheumatology Reports.

[13]  F. Nuttall.  Body Mass Index , 2015, Nutrition today.

[14]  Alan D. Lopez,et al.  Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2014, The Lancet.

[15]  T. Vos,et al.  The global burden of gout: estimates from the Global Burden of Disease 2010 study , 2014, Annals of the rheumatic diseases.

[16]  S. Juraschek,et al.  Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010 , 2013, Arthritis care & research.

[17]  W. Pan,et al.  Impact of obesity and hypertriglyceridemia on gout development with or without hyperuricemia: A prospective study , 2013, Arthritis care & research.

[18]  B. Arroll,et al.  National prevalence of gout derived from administrative health data in Aotearoa New Zealand. , 2012, Rheumatology.

[19]  B. Swinburn,et al.  The global obesity pandemic: shaped by global drivers and local environments , 2011, The Lancet.

[20]  Nicola Dalbeth,et al.  The genetic basis of hyperuricaemia and gout. , 2011, Joint, bone, spine : revue du rhumatisme.

[21]  T. Merriman,et al.  A strong role for the ABCG2 gene in susceptibility to gout in New Zealand Pacific Island and Caucasian, but not Māori, case and control sample sets. , 2010, Human molecular genetics.

[22]  D. Hernandez,et al.  Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors , 2010, Circulation. Cardiovascular genetics.

[23]  R. Torres,et al.  Metabolic Syndrome Characteristics in Gout Patients , 2010, Nucleosides, nucleotides & nucleic acids.

[24]  P. Metcalf,et al.  Overweight and obesity prevalence among adult Pacific peoples and Europeans in the Diabetes Heart and Health Study (DHAHS) 2002-2003, Auckland New Zealand. , 2010, The New Zealand medical journal.

[25]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[26]  F. Grodstein,et al.  Menopause, postmenopausal hormone use and risk of incident gout , 2009, Annals of the rheumatic diseases.

[27]  A. Lagro-Janssen,et al.  “Clinical features of women with gout arthritis.” A systematic review , 2010, Clinical Rheumatology.

[28]  T. Merriman,et al.  Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. , 2009, Arthritis and rheumatism.

[29]  S. Daniels,et al.  The Use of BMI in the Clinical Setting , 2009, Pediatrics.

[30]  A. Hofman,et al.  Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study , 2008, The Lancet.

[31]  T. Olds,et al.  Relationship between adiposity and body size reveals limitations of BMI. , 2006, American journal of physical anthropology.

[32]  N. Dalbeth,et al.  Mechanisms of inflammation in gout. , 2005, Rheumatology.

[33]  Hyon K. Choi,et al.  Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. , 2005, Archives of internal medicine.

[34]  J. Seidell,et al.  [The value and limitations of the body mass index (BMI) in the assessment of the health risks of overweight and obesity]. , 2004, Nederlands tijdschrift voor geneeskunde.

[35]  E. Feuer,et al.  Partitioning linear trends in age-adjusted rates , 2004, Cancer Causes & Control.

[36]  G. Curhan,et al.  The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  Y. Moriwaki,et al.  Increased visceral fat accumulation further aggravates the risks of insulin resistance in gout. , 2001, Metabolism: clinical and experimental.

[38]  Y. Moriwaki,et al.  Increased visceral fat accumulation in patients with primary gout. , 2000, Advances in experimental medicine and biology.

[39]  K. Liang,et al.  Incidence and risk factors for gout in white men. , 1991, JAMA.

[40]  V M Hawthorne,et al.  Three limitations of the body mass index. , 1986, The American journal of clinical nutrition.

[41]  K. Bremner,et al.  Hyperuricaemia, gout and kidney function in New Zealand Maori men. , 1984, British journal of rheumatology.

[42]  R. Acheson.  Heberden Oration 1981: epidemiology and the arthritides. , 1982, Annals of the rheumatic diseases.

[43]  D. Mccarty,et al.  Preliminary criteria for the classification of the acute arthritis of primary gout. , 1977, Arthritis and rheumatism.

[44]  L. A. Healey.  Epidemiology of hyperuricemia. , 1975, Arthritis and rheumatism.

[45]  R. Acheson.  Epidemiology of serum uric acid and gout: an example of the complexities of multifactorial causation. , 1970, Proceedings of the Royal Society of Medicine.